Abstract

The present invention belongs to the field of therapeutic treatments of cancer diseases, particularly solid tumors such as melanoma, cancers of the gastrointestinal tract and thyroid carcinoma. The use of a melanocortin 4 receptor antagonist offers a possible new target therapy in the treatment of cancer diseases, counteracting the possibility of recurrence.

Research Institution

Università di Pisa

Numero di pubblicazione

WO2019243974A1

TRL

3

Technologies, Systems, Applications

Biomedical, New drugs development